TrialClinical and vaccine immunology : CVI2017

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

André G Loxton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.